Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPuma Biotechnology Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | $0.04 | $0.04 | $0.04 |
| Q2 2026 | 1 | $0.12 | $0.12 | $0.12 |
| Q3 2026 | 1 | $0.18 | $0.18 | $0.18 |
| Q4 2026 | 1 | $0.22 | $0.22 | $0.22 |
Puma Biotechnology Inc Earnings Date And Information
Puma Biotechnology Inc last posted its earnings results on Thursday, November 6th, 2025. The company reported $0.21 earnings per share for the quarter, topping analysts' consensus estimates of $0.09 by $0.12. The company had revenue of 54.48 M for the quarter and had revenue of 230.47 M for the year. Puma Biotechnology Inc has generated $1 earnings per share over the last year ($0.62 diluted earnings per share) and currently has a price-to-earnings ratio of 9.09. Puma Biotechnology Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Puma Biotechnology Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2025 | Q3 2025 | $0.09 | $0.18 | 0.09 | $51.00 M | $54.48 M |
| 08/07/2025 | Q2 2025 | $0.11 | $0.12 | 0.01 | $52.00 M | $52.44 M |
| 05/08/2025 | Q1 2025 | $0.02 | $0.06 | 0.04 | N/A | $46.01 M |
| 02/27/2025 | Q4 2024 | $0.10 | $0.39 | 0.29 | N/A | $59.08 M |
| 11/07/2024 | Q3 2024 | $0.35 | $0.41 | 0.06 | $70.65 M | $80.54 M |
| 08/01/2024 | Q2 2024 | -$0.10 | -$0.09 | 0.01 | $44.70 M | $47.08 M |
| 05/02/2024 | Q1 2024 | -$0.16 | -$0.10 | 0.06 | N/A | $43.77 M |
| 02/29/2024 | Q4 2023 | $0.30 | $0.26 | -0.04 | N/A | $72.18 M |
| 11/02/2023 | Q3 2023 | $0.08 | $0.12 | 0.04 | N/A | $56.12 M |
| 08/03/2023 | Q2 2023 | $0.07 | $0.05 | -0.02 | N/A | $54.57 M |
| 05/04/2023 | Q1 2023 | $0.04 | $0.03 | -0.01 | N/A | $52.78 M |
| 03/02/2023 | Q4 2022 | $0.06 | -$0.12 | -0.18 | N/A | $65.68 M |
| 11/03/2022 | Q3 2022 | -$0.11 | -$0.01 | 0.1 | N/A | $57.10 M |
| 08/04/2022 | Q2 2022 | $0.00 | $0.21 | 0.21 | N/A | $59.52 M |
| 05/05/2022 | Q1 2022 | -$0.13 | -$0.08 | 0.05 | N/A | $45.74 M |
| 03/03/2022 | Q4 2021 | -$0.09 | $0.10 | 0.19 | N/A | $55.36 M |
| 11/04/2021 | Q3 2021 | -$0.23 | -$1.09 | -0.86 | N/A | $46.25 M |
| 08/05/2021 | Q2 2021 | -$0.31 | -$0.13 | 0.18 | N/A | $53.38 M |
| 05/06/2021 | Q1 2021 | $0.09 | $0.41 | 0.32 | N/A | $98.17 M |
| 03/01/2021 | Q4 2020 | N/A | -$0.38 | N/A | N/A | $52.56 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Puma Biotechnology Inc Earnings: FAQ's
In the previous quarter, Puma Biotechnology Inc (:PBYI) reported $0.21 earnings per share (EPS) to beat the analysts' consensus estimate of $0.09 by $0.12.
The conference call for Puma Biotechnology Inc's latest earnings report can be listened to online.
The conference call transcript for Puma Biotechnology Inc's latest earnings report can be read online.
Puma Biotechnology Inc (:PBYI) has a recorded annual revenue of $230.47 M.
Puma Biotechnology Inc (:PBYI) has a recorded net income of $30.28 M.Puma Biotechnology Inc has generated $0.62 earnings per share over the last four quarters.
Puma Biotechnology Inc (:PBYI) has a price-to-earnings ratio of 9.09 and price/earnings-to-growth ratio is -0.39.